Aarti Pharmalabs Limited
Aarti Pharmalabs Limited (AARTIPHARM.NS) Stock Overview
Explore Aarti Pharmalabs Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
64.2B
P/E Ratio
30.04
EPS (TTM)
$23.56
ROE
0.11%
AARTIPHARM.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Aarti Pharmalabs Limited (AARTIPHARM.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1037.29.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.04 and a market capitalization of 64.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.